NVP-SAA164
SMILES | CN1CCN(CC1)C(=O)C1CCN(CC1)S(=O)(=O)c1ccc(c(c1)C(=O)N1CCOCC1)NCC(c1ccccc1)c1ccccc1 |
InChIKey | VODUCDWVPSEMSZ-UHFFFAOYSA-N |
Chemical properties
Hydrogen bond acceptors | 7 |
Hydrogen bond donors | 1 |
Rotatable bonds | 9 |
Molecular weight (Da) | 659.3 |
Drug properties
Molecular type | Small molecule |
Endogenous/Surrogate | Surrogate |
Approved drug | No |
Database connections
Bioactivities
Receptor | Activity | Source | |||||||
---|---|---|---|---|---|---|---|---|---|
GTP | Uniprot | Species | Family | Class | Type | Min | Avg | Max | Database |
D2 | DRD2 | Human | Dopamine | A | pKi | 9.85 | 9.85 | 9.85 | Guide to Pharmacology |
D1 | DRD1 | Rat | Dopamine | A | pKi | 5.54 | 5.54 | 5.54 | PDSP Ki database |
D2 | DRD2 | Rat | Dopamine | A | pKi | 7.83 | 7.83 | 7.83 | PDSP Ki database |
H1 | HRH1 | Rat | Histamine | A | pKi | 5.52 | 5.52 | 5.52 | PDSP Ki database |
β2 | ADRB2 | Rat | Adrenoceptors | A | pKi | 5.0 | 5.0 | 5.0 | PDSP Ki database |
5-HT2A | 5HT2A | Human | 5-Hydroxytryptamine | A | pKi | 8.04 | 8.04 | 8.04 | Drug Central |
α1A | ADA1A | Human | Adrenoceptors | A | pKi | 8.14 | 8.14 | 8.14 | Drug Central |
D2 | DRD2 | Human | Dopamine | A | pKi | 8.01 | 8.01 | 8.01 | Drug Central |
5-HT2A | 5HT2A | Human | 5-Hydroxytryptamine | A | pKi | 9.09 | 9.09 | 9.09 | ChEMBL |
5-HT2A | 5HT2A | Human | 5-Hydroxytryptamine | A | pKi | 9.09 | 9.09 | 9.09 | Guide to Pharmacology |
D2 | DRD2 | Human | Dopamine | A | pKi | 9.85 | 9.85 | 9.85 | ChEMBL |
Receptor | Activity | Source | |||||||
---|---|---|---|---|---|---|---|---|---|
GTP | Uniprot | Species | Family | Class | Type | Min | Avg | Max | Database |